Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Electronic Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
3.2.1.2. Rising preference for home healthcare
3.2.1.3. Integration of digital technologies and growing awareness of personalized medications
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced drug delivery devices
3.2.2.2. Limited patient awareness and device-related complications
3.3. Key Technology Trends
3.4. Key Brands
3.5. Pipeline Analysis
3.6. Electronic Drug Delivery Devices Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Bargaining power of suppliers
3.6.1.2. Bargaining power of buyers
3.6.1.3. Threat of substitutes
3.6.1.4. Threat of new entrants
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic landscape
3.6.2.3. Social landscape
3.6.2.4. Technological landscape
3.6.2.5. Environmental landscape
3.6.2.6. Legal landscape
Chapter 4. Electronic Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Electronic Drug Delivery Devices Market: Product Movement Analysis
4.3. Electronic Drug Delivery Devices Market by Product Outlook (Revenue, USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.5. Smart Infusion Pumps (Infusion Systems)
4.5.1. Smart Infusion Pumps (Infusion Systems) Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.5.1.1. Non-biologic Smart Infusion Systems
4.5.1.1.1. Non-biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.5.1.2. Biologic Smart Infusion Systems
4.5.1.2.1. Biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.5.1.2.1.1. Smart Infusion Insulin Pumps
4.5.1.2.1.1.1. Smart Infusion Insulin Pumps Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.5.1.2.1.2. Others
4.5.1.2.1.2.1. Others Market Revenue Estimated and Forecasts, 2018-2030 (Revenue, USD Million)
4.6. Smart Metered Dose Inhalers (Inhalation Devices)
4.6.1. Smart Metered Dose Inhalers (Inhalation Devices) Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.7. Implantable Drug Delivery Devices
4.7.1. Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.7.1.1. Biologic Implantable Drug Delivery Devices
4.7.1.1.1. Biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
4.7.1.2. Non-biologic Implantable Drug Delivery Devices
4.7.1.2.1. Non-biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
Chapter 5. Electronic Drug Delivery Devices Market: Application Estimated & Trend Analysis
5.1. Segment Dashboard
5.2. Electronic Drug Delivery Devices Market: Application Movement Analysis
5.3. Electronic Drug Delivery Devices Market by Application Outlook (Revenue, USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.5. Diabetes
5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
5.6. Respiratory Diseases
5.6.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
5.7. Oncology
5.7.1. Oncology Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
5.8. Cardiology
5.8.1. Cardiology Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
Chapter 6. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Electronic Drug Delivery Devices Market Movement Analysis
6.3. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Product
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
6.5. North America
6.5.1. North America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement scenario
6.5.4.5. Mexico Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6. Europe
6.6.1. Europe Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. UK Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Germany Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. France Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. Italy Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Spain Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.7. Denmark
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Denmark Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Sweden Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.6.9. Norway
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement scenario
6.6.9.5. Norway Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.2. Japan
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Japan Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.3. China
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. China Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.4. India
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. India Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Reimbursement scenario
6.7.5.5. South Korea Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.6. Australia
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Australia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.7.7. Thailand
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Thailand Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.8. Latin America
6.8.1. Latin America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.8.2. Brazil
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. Brazil Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.8.3. Argentina
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Argentina Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.9. Middle East & Africa
6.9.1. Middle East & Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.9.2. South Africa
6.9.2.1. Key Country Dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory Framework
6.9.2.4. Reimbursement scenario
6.9.2.5. South Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key Country Dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory Framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.9.4. UAE
6.9.4.1. Key Country Dynamics
6.9.4.2. Competitive Scenario
6.9.4.3. Regulatory Framework
6.9.4.4. Reimbursement scenario
6.9.4.5. UAE Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
6.9.5. Kuwait
6.9.5.1. Key Country Dynamics
6.9.5.2. Competitive Scenario
6.9.5.3. Regulatory Framework
6.9.5.4. Reimbursement scenario
6.9.5.5. Kuwait Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Medtronic plc
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Insulet Corporation
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Becton, Dickinson and Company
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Tandem Diabetes Care, Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Ypsomed AG
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Novo Nordisk a/S
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Sanofi S.A.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Eli, Lilly and Company
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. AstraZeneca plc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. GlaxoSmithKline plc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Boehringer Ingelheim International GmbH
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Pfizer, Inc.
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Teva Pharmaceutical Industries
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Phillips-Medisize, LLC
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. West Pharmaceutical Services, Inc.
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. Gerresheimer AG
7.2.16.1. Company Overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives
7.2.17. Nemera Group
7.2.17.1. Company overview
7.2.17.2. Financial performance
7.2.17.3. Product benchmarking
7.2.17.4. Strategic initiatives
7.2.18. SHL Group
7.2.18.1. Company overview
7.2.18.2. Financial performance
7.2.18.3. Product benchmarking
7.2.18.4. Strategic initiatives
7.2.19. Owen Mumford
7.2.19.1. Company overview
7.2.19.2. Financial performance
7.2.19.3. Product benchmarking
7.2.19.4. Strategic initiatives
7.2.20. Haselmeier AG
7.2.20.1. Company overview
7.2.20.2. Financial performance
7.2.20.3. Product benchmarking
7.2.20.4. Strategic initiatives
7.2.21. ICU Medical
7.2.21.1. Company overview
7.2.21.2. Financial performance
7.2.21.3. Product benchmarking
7.2.21.4. Strategic initiatives
7.2.22. Hisamitsu Pharmaceutical Co., Inc.
7.2.22.1. Company overview
7.2.22.2. Financial performance
7.2.22.3. Product benchmarking
7.2.22.4. Strategic initiatives
7.2.23. Sparsha Pharma International
7.2.23.1. Company overview
7.2.23.2. Financial performance
7.2.23.3. Product benchmarking
7.2.23.4. Strategic initiatives
7.2.24. Baxter International, Inc.
7.2.24.1. Company overview
7.2.24.2. Financial performance
7.2.24.3. Product benchmarking
7.2.24.4. Strategic initiatives
7.2.25. Fresenius Kabi AG
7.2.25.1. Company overview
7.2.25.2. Financial performance
7.2.25.3. Product benchmarking
7.2.25.4. Strategic initiatives
7.2.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7.2.26.1. Company overview
7.2.26.2. Financial performance
7.2.26.3. Product benchmarking
7.2.26.4. Strategic initiatives
7.2.27. Novartis AG
7.2.27.1. Company overview
7.2.27.2. Financial performance
7.2.27.3. Product benchmarking
7.2.27.4. Strategic initiatives
7.2.28. AptarGroup, Inc.
7.2.28.1. Company overview
7.2.28.2. Financial performance
7.2.28.3. Product benchmarking
7.2.28.4. Strategic initiatives
7.2.29. Teleflex Incorporates
7.2.29.1. Company overview
7.2.29.2. Financial performance
7.2.29.3. Product benchmarking
7.2.29.4. Strategic initiatives
7.2.30. Abbott Laboratories
7.2.30.1. Company overview
7.2.30.2. Financial performance
7.2.30.3. Product benchmarking
7.2.30.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 4 Global electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 5 North America electronic drug delivery devices market, by region, 2018-2030 (Revenue, USD Million)
Table 6 North America electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 7 North America electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 8 U.S electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 9 U.S electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 10 Canada electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 11 Canada electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 12 Mexico electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 13 Mexico electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 14 Europe electronic drug delivery devices market, by country, 2018-2030 (Revenue, USD Million)
Table 15 Europe electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 16 Europe electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 17 UK electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 18 UK electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 19 Germany electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 20 Germany electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 21 France electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 22 France electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 23 Italy electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 24 Italy electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 25 Spain electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 26 Spain electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 27 Norway electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 28 Norway electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 29 Sweden electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 30 Sweden electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 31 Denmark electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 32 Denmark electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 33 Asia Pacific electronic drug delivery devices market, by country, 2018-2030 (Revenue, USD Million)
Table 34 Asia Pacific electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 35 Asia Pacific electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 36 Japan electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 37 Japan electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 38 China electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 39 China electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 40 India electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 41 India electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 42 Australia electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 43 Australia electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 44 South Korea electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 45 South Korea electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 46 Thailand electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 47 Thailand electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 48 Latin America electronic drug delivery devices market, by country, 2018-2030 (Revenue, USD Million)
Table 49 Latin America electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 50 Latin America electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 51 Brazil electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 52 Brazil electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 53 Argentina electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 54 Argentina electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 55 Middle East & Africa electronic drug delivery devices market, by country, 2018-2030 (Revenue, USD Million)
Table 56 Middle East & Africa electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 57 Middle East & Africa electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 58 South Africa electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 59 South Africa electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 60 Saudi Arabia electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 61 Saudi Arabia electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 62 UAE electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 63 UAE electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
Table 64 Kuwait electronic drug delivery devices market, by product, 2018-2030 (Revenue, USD Million)
Table 65 Kuwait electronic drug delivery devices market, by application, 2018-2030 (Revenue, USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Electronic drug delivery devices market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis by Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Electronic drug delivery devices market, product outlook key takeaways (Revenue, USD Million)
Figure 12 Electronic drug delivery devices market: product movement analysis (Revenue, USD Million), 2023 & 2030
Figure 13 Smart infusion pumps (infusion systems) market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 14 Non-biologic smart infusion systems market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 15 Biologic smart infusion systems market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 16 Smart infusion insulin pumps market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Figure 17 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Figure 18 Smart metered dose inhalers (inhalation devices) market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Figure 20 Biologic implantable drug delivery devices market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 21 Non-biologic implantable drug delivery devices market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 22 Smart transdermal patches (transdermal delivery systems) market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 23 Others market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Electronic drug delivery devices market, application outlook key takeaways (Revenue, USD Million)
Figure 25 Electronic drug delivery devices market: application movement analysis (Revenue, USD Million), 2023 & 2030
Figure 26 Diabetes market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 27 Respiratory Diseases market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 28 Oncology market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 29 Cardiology market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 30 Others market revenue estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 31 Electronic drug delivery devices market: Regional key takeaways (Revenue, USD Million)
Figure 32 Electronic drug delivery devices market: regional outlook, 2023 & 2030, (Revenue, USD Million)
Figure 33 North America electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 34 US electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 35 Canada electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 36 Mexico electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 37 Europe electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 38 UK electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 39 Germany electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 40 France electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 41 Spain electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 42 Italy electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 43 Sweden electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 44 Norway electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 45 Denmark electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 46 Asia Pacific electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 47 China electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 48 Japan electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 49 India electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million
Figure 50 South Korea electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 51 Australia electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 52 Thailand electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 53 Latin America electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 54 Brazil electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 55 Argentina electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 56 Middle East and Africa electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 57 South Africa electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 58 Saudi Arabia electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 59 UAE electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 60 Kuwait electronic drug delivery devices market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Figure 61 List of key emerging company’s/technology disruptors/innovators
